ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 185 filers reported holding ACCELERON PHARMA INC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $162,000 | -14.3% | 4,101 | -10.9% | 0.01% | -14.3% |
| Q2 2019 | $189,000 | -89.2% | 4,603 | -87.8% | 0.01% | -90.8% |
| Q1 2019 | $1,756,000 | +6.9% | 37,700 | 0.0% | 0.08% | -23.2% |
| Q4 2018 | $1,642,000 | -55.3% | 37,700 | -41.2% | 0.10% | -45.0% |
| Q3 2018 | $3,670,000 | +16.1% | 64,125 | -1.6% | 0.18% | +13.2% |
| Q2 2018 | $3,161,000 | +30.7% | 65,143 | +5.3% | 0.16% | -5.4% |
| Q1 2018 | $2,418,000 | – | 61,847 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 917,767 | $52,524,000 | 8.19% |
| Foresite Capital Management II, LLC | 220,268 | $12,606,000 | 4.66% |
| Foresite Capital Management III, LLC | 250,863 | $14,357,000 | 3.17% |
| Novo Holdings A/S | 650,000 | $37,200,000 | 2.95% |
| QVT Financial LP | 190,977 | $10,930,000 | 2.82% |
| Perceptive Advisors | 1,528,205 | $87,459,000 | 2.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,117,651 | $63,963,000 | 2.29% |
| Asymmetry Capital Management, L.P. | 39,912 | $2,284,000 | 2.11% |
| SECTORAL ASSET MANAGEMENT INC | 298,726 | $17,096,000 | 1.82% |
| Stanley-Laman Group, Ltd. | 125,020 | $7,155,000 | 1.76% |